CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
157 hedge funds and large institutions have $328M invested in Clovis Oncology, Inc. in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 59 increasing their positions, 38 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+4
Holders Change %
+2.61%
% of All Funds
3.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
35
Increased
59
Reduced
38
Closed
30
Calls
$31.7M
Puts
$23.7M
Net Calls
+$8.06M
Net Calls Change
-$24M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$62.4M |
| 2 |
BlackRock
New York
|
$38M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$42.2M |
| 4 |
AC
Armistice Capital
New York
|
$10.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$10.7M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
$1.14M |
| 2 |
AG
Artal Group
Luxembourg
|
$0 |
| 3 |
CAC
Cowen and Company
New York
|
$0 |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
$101K |
| 5 |
SG Americas Securities
New York
|
$1.37M |
